Toxic epidermal necrolysis in HIV-infected patients: are intravenous immunoglobulins really necessary in this subgroup?
María Clara MancinelliHernán FeolaAgustina Mariel D' AlessandroMaría Alejandra VereaPublished in: International journal of STD & AIDS (2020)
The spectrum of Stevens-Johnson syndrome/toxic epidermal necrolysis (TEN) is the most severe form of cutaneous adverse reactions to drugs. We report a case of a HIV-positive man with TEN who presented a very good response to a single dose of intravenous immunoglobulins and a short pulse of corticosteroids, together with intensive supportive care. Although the largest study on the management of this type of patients reported to date suggests a scheme of three doses of intravenous immunoglobulins together with glucocorticoids, we implemented a single dose of immunoglobulins due to lack of availability.
Keyphrases
- hiv positive
- antiretroviral therapy
- hiv infected patients
- end stage renal disease
- high dose
- men who have sex with men
- hiv infected
- south africa
- human immunodeficiency virus
- healthcare
- chronic kidney disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- blood pressure
- palliative care
- prognostic factors
- clinical trial
- early onset
- randomized controlled trial
- low dose
- open label
- phase iii
- drug induced
- study protocol